AlphaYouOM
Insider selling
Opaleye Management Inc. sold $4.8M of Eton Pharmaceuticals, Inc. (ETON) stock
Opaleye Management Inc., 10% owner of Eton Pharmaceuticals, Inc. (ETON), sold 126,685 shares of ETON stock worth $4.8M, per an SEC Form 4 filed Jul 7, 2026.
It was an open-market sale.
The trade happened on Jul 2, 2026, 5 days before it was made public.
ETON has moved +47.5% since the trade date, from $37.50 to $55.31 (Sep 21, 2026 close).
- Traded
- Jul 2, 2026
- Disclosed
- Jul 7, 2026
- Filing delay
- 5 days
- Price since
- +47.5%
- Role
- 10% owner
- Source
- SEC Form 4
More ETON insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.